Table 5.
Baseline outcome measures for completers and noncompleters
| POQ |
PCS | ISI | Pain NRS | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Program | MOB | ADL | VIT | NA | Fear | Total | Total | Total | Average | |
| ABQ | Completers | 23.86 (9.94) | 9.94 (10.11) | 19.15 (5.43) | 27.10 (11.88) | 9.75 (4.95) | 96.55 (31.45) | 28.33 (13.02) | 17.43 (7.70) | 6.74 (1.53) |
| Noncompleters | 22.67 (9.66) | 10.61 (10.69) | 18.11 (4.55) | 32.17 (7.96) | 10.33 (4.68) | 100.06 (23.5) | 35.06 (11.26) | 19.72 (7.09) | 6.17 (1.38) | |
| t (df)* | 0.48 (133) | −0.26 (133) | 0.77 (133) | −1.75 (133) | −0.47 (133) | −0.45 (133) | −3.62 (133)* | −1.19 (133) | 1.49 (133) | |
| CLE | Completers | 25.73 (8.25) | 10.70 (9.75) | 19.93 (4.73) | 24.18 (11.03) | 10.79 (3.38) | 98.07 (28.03) | 28.61 (13.01) | 16.58 (7.32) | 6.75 (1.71) |
| Noncompleters | 26.21 (9.81) | 10.48 (10.52) | 19.55 (6.08) | 19.55 (6.08) | 10.03 (4.64) | 102.12 (28.54) | 26.48 (13.79) | 16.79 (6.95) | 7.21 (1.43) | |
| t (df)* | 0.85 (96) | 0.74 (96) | 0.91 (96) | 0.91 (96) | 1.36 (96) | 1.16 (96) | 1.22 (96) | 0.76 (96) | 1.71 (96) | |
| PS | Completers | 24.25 (9.27) | 10.51 (9.27) | 18.60 (5.35) | 26.12 (11.16) | 9.55 (4.67) | 96.13 (29.94) | 23.13 (12.54) | 16.73 (5.96) | 6.48 (1.71) |
| Noncompleters | 27.17 (7.29) | 11.52 (10.79) | 18.88 (8.54) | 25.94 (9.36) | 8.00 (4.94) | 98.82 (25.23) | 23.84 (11.12) | 17.68 (5.55) | 6.35 (1.85) | |
| t (df)* | −1.47 (146) | 0.36 (146) | 0.17 (146) | −0.07 (146) | −1.36 (146) | 5.14 (146) | 0.29 (142) | −0.63 (173) | 5.14 (145) | |
| SF | Completers | 23.44 (10.60) | 9.47 (10.23) | 20.80 (4.98) | 26.80 (12.51) | 12.78 (4.61) | 99.51 (31.61) | 28.93 (14.27) | 15.98 (6.63) | 6.22 (2.09) |
| Noncompleters | 24.25 (9.47) | 10.82 (8.97) | 17.50 (5.42) | 28.86 (10.68) | 11.46 (4.32) | 99.89 (28.03) | 26.58 (13.41) | 17.04 (6.88) | 7.00 (1.72) | |
| t (df)* | 0.33 (71) | 0.58 (71) | −2.66 (71)* | 0.72 (71) | −1.21 (71) | 0.05 (71) | −0.69 (69) | 0.64 (68) | 1.65 (71) | |
| TPA-IN | Completers | 25.37 (9.5) | 14.16 (10.6) | 19.55 (5.07) | 27.92 (11.32) | 11.29 (4.57) | 98.29 (27.9) | 28.07 (12.49) | 17.89 (5.72) | 6.87 (1.53) |
| Noncompleters | 24.83 (8.89) | 13.04 (11.61) | 20.33 (6.06) | 29.79 (10.10) | 12.38 (5.01) | 100.38 (32.67) | 25.87 (13.89) | 18.13 (5.04) | 7.17 (1.49) | |
| t (df)* | 0.27 (386) | 0.49 (386) | −0.72 (386) | −0.79 (386) | −1.12 (386) | −0.39 (386) | 0.82 (385) | −0.19 (386) | −0.91 (386) | |
| TPA-OUT | Completers | 24.24 (9.6) | 15.98 (11.65) | 18.22 (4.13) | 24.71 (12.89) | 12.64 (3.98) | 95.80 (32.71) | 25.57 (13.1) | 17.36 (7.12) | 6.89 (1.34) |
| Noncompleters | 26.07 (7.92) | 15.86 (10.09) | 20.93 (4.49) | 25.50 (14.34) | 12.71 (4.84) | 101.07 (31.53) | 22.07 (14.06) | 15.71 (6.63) | 6.79 (1.72) | |
| t (df)* | −0.65 (57) | 0.04 (57) | −2.09 (57)* | −0.19 (57) | −0.05 (57) | −0.53 (57) | 0.86 (56) | 0.77 (57) | 0.24 (57) | |
POQ = Pain Outcomes Questionnaire; PCS = Pain Catastrophizing Scale; ISI = Insomnia Sleep Index; NRS = numeric rating scale; MOB = mobility; ADL = activities of daily living; VIT = vitality; NA = negative affect; ABQ = Albuquerque; CLE = Cleveland; PS = Puget Sound; SF = San Francisco; TPA = Tampa, IN = inpatient; OUT = outpatient; t=t score; df = degrees of freedom.
Independent-samples t test analyses were used to identify statistically significant differences between completers and noncompleters.
*
Significant at 0.05 level.